These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10359345)

  • 41. [Natamycin (pimaricin) in the treatment of experimental keratomycosis].
    Behrens-Baumann W; Klinge B
    Fortschr Ophthalmol; 1990; 87(3):237-40. PubMed ID: 2376371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of preoperative and postoperative prophylactic regimens for prevention and treatment of diffuse lamellar keratitis.
    Holzer MP; Sandoval HP; Vargas LG; Kasper TJ; Vroman DT; Apple DJ; Solomon KD
    J Cataract Refract Surg; 2004 Jan; 30(1):195-9. PubMed ID: 14967290
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathogenesis and outcome of Paecilomyces keratitis.
    Yuan X; Wilhelmus KR; Matoba AY; Alexandrakis G; Miller D; Huang AJ
    Am J Ophthalmol; 2009 Apr; 147(4):691-696.e3. PubMed ID: 19195638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fungal keratitis and contact lenses: an old enemy unrecognized or a new nemesis on the block?
    Tuli SS; Iyer SA; Driebe WT
    Eye Contact Lens; 2007 Nov; 33(6 Pt 2):415-7; discussion 424-5. PubMed ID: 17975436
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Natamycin treatment of experimental Candida albicans induced keratomycosis in rabbits.
    Saleem M; Rahman A; Afza N
    West Indian Med J; 2007 Dec; 56(6):526-9. PubMed ID: 18646497
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hyphal growth patterns and recurrence of fungal keratitis after lamellar keratoplasty.
    Xie L; Zhai H; Shi W; Zhao J; Sun S; Zang X
    Ophthalmology; 2008 Jun; 115(6):983-7. PubMed ID: 17919731
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microplasma Jet Arrays as a Therapeutic Choice for Fungal Keratitis.
    Park HJ; Kim SH; Ju HW; Lee H; Lee Y; Park S; Yang H; Park SJ; Eden JG; Yang J; Park CH
    Sci Rep; 2018 Feb; 8(1):2422. PubMed ID: 29403058
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of collagen shields containing amphotericin B in the treatment of experimental Candida albicans-induced keratomycosis in rabbits.
    Pleyer U; Legmann A; Mondino BJ; Lee DA
    Am J Ophthalmol; 1992 Mar; 113(3):303-8. PubMed ID: 1543224
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of lectin staining in the diagnosis of fungal keratitis in an experimental rabbit model.
    Garcia ML; Herreras JM; Dios E; Argueso P; Almaraz A
    Mol Vis; 2002 Jan; 8():10-6. PubMed ID: 11815751
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anomalous effect of subconjunctival miconazole on Candida albicans keratitis in rabbits.
    O'Day DM; Head WS; Robinson RD; Williams TE; Gedde SJ
    Am J Ophthalmol; 1991 Nov; 112(5):562-6. PubMed ID: 1951595
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mycobacterium fortuitum keratitis. Clinicopathologic correlates and corticosteroid effects in an animal model.
    Paschal JF; Holland GN; Sison RF; Berlin OG; Bruckner DA; Dugel PU; Foos RY
    Cornea; 1992 Nov; 11(6):493-9. PubMed ID: 1468210
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current concepts: contact lens related Pseudomonas keratitis.
    Robertson DM; Petroll WM; Jester JV; Cavanagh HD
    Cont Lens Anterior Eye; 2007 May; 30(2):94-107. PubMed ID: 17084658
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Matrix metalloproteinases (MMP-8, MMP-9) and the tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2) in patients with fungal keratitis.
    Rohini G; Murugeswari P; Prajna NV; Lalitha P; Muthukkaruppan V
    Cornea; 2007 Feb; 26(2):207-11. PubMed ID: 17251814
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of extracellular phospholipase B of Candida albicans as a virulent factor in experimental keratomycosis.
    Ma L; Xie L; Dong X; Shi W
    Curr Eye Res; 2009 Sep; 34(9):761-8. PubMed ID: 19839869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The clinical features and study on therapeutic effects of fungal keratitis].
    He Y; Sun B; Zhao D; Wang Y; Li J; Zhu L
    Zhonghua Yan Ke Za Zhi; 2000 Sep; 36(5):358-61. PubMed ID: 11853629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antifungal efficacy of GM237354, a sordarin derivative, in experimental oral candidiasis in immunosuppressed rats.
    Martinez A; Regadera J; Jimenez E; Santos I; Gargallo-Viola D
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1008-13. PubMed ID: 11257009
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent pattern of contact lens-related keratitis in Hong Kong.
    Yu DK; Ng AS; Lau WW; Wong CC; Chan CW
    Eye Contact Lens; 2007 Nov; 33(6 Pt 1):284-7. PubMed ID: 17993822
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Time course of experimental Pseudomonas aeruginosa keratitis in contact lens overwear.
    Lawin-Brüssel CA; Refojo MF; Leong FL; Hanninen L; Kenyon KR
    Arch Ophthalmol; 1990 Jul; 108(7):1012-9. PubMed ID: 2114865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Corneal neovascularization during experimental fungal keratitis.
    Yuan X; Wilhelmus KR
    Mol Vis; 2009 Sep; 15():1988-96. PubMed ID: 19816603
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel rat contact lens model for Fusarium keratitis.
    Abou Shousha M; Santos AR; Oechsler RA; Iovieno A; Maestre-Mesa J; Ruggeri M; Echegaray JJ; Dubovy SR; Perez VL; Miller D; Alfonso EC; Bajenaru ML
    Mol Vis; 2013; 19():2596-605. PubMed ID: 24379647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.